10.07.2025 • NewsArkemainvestmentpolyamide

Arkema Invests in New Polyamide Unit in Singapore

Arkema recently increased its global Rilsan polyamide 11 production by 50% after opening a new plant in Singapore. The company is now building another unit at the same site to produce Rilsan Clear, a transparent polyamide. This new project will cost about $20 million and is expected to start operating in early 2026.

This investment will increase Arkema’s global production capacity of Rilsan Clear transparent polyamides by three times. The additional capacity is intended to address rising demand for high-performance transparent materials in markets such as eyewear, consumer electronics, healthcare devices, and home appliances.

Arkema produces bio-based transparent polyamides, including Rilsan Clear Rnew G850 and G820, which contain 45% and 62% bio-based carbon, respectively. These materials are designed to be lightweight, transparent, flexible, and resistant to chemicals and temperature changes, and can be recycled through Arkema’s Virtucycle program.

“We are very proud to take this new step forward with this expansion dedicated to transparent polyamides as it aligns with the evolving demand landscape, showcasing our commitment to global growth” said Laurent Tellier, Senior Vice-President High Performance Polymers and Fluorogases. “It marks the next step in developing our strategic platform in Singapore to support our valued customers in Asia and beyond.” 

The project will also contribute to Arkema’s strategy to develop local supply from the region to the region, providing customers with shorter lead times, resilient and competitive local supply chains.

Company

Logo:

Arkema

420 rue d’Estienne d’Orves
92705 Colombes Cedex
France

Company contact







Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.